½ÃÀ庸°í¼­
»óǰÄÚµå
1296747

¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ¿¹Ãø : ¼­ºñ½º À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®(-2028³â)

Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - Global Analysis By Service Type, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 156 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀº 2022³â 20¾ï 5,000¸¸ ´Þ·¯¿¡¼­ 2028³â¿¡´Â 35¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2028³â±îÁö 9.9%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº µ¿°á°ÇÁ¶ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼¼°èÀûÀ¸·Î ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â À§Å¹»ý»ê ¹× µ¿°á°ÇÁ¶ ¼­ºñ½º¿¡ ±âÀÎÇÕ´Ï´Ù. ±×·¯³ª µ¿°á°ÇÁ¶ °øÁ¤°ú °ü·ÃµÈ ´ÜÁ¡ÀÌ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÏ´Â µ¿°á°ÇÁ¶ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

µ¿°á°ÇÁ¶´Â Àç·áÀÇ ¼öºÐÀ» Á¦°ÅÇÏ¿© ¾ÈÁ¤¼º°ú º¸Á¸±â°£À» ¿¬ÀåÇÏ´Â µ¿°á°ÇÁ¶ ¹æ¹ýÀÔ´Ï´Ù. µ¿°á °ÇÁ¶·Î ó¸®µÈ Á¦Ç°Àº °íÁø°ø ÇÏ¿¡¼­ µ¿°áµÇ¸ç, ÁÖ·Î Á¦¾à »ê¾÷¿¡¼­ °íǰÁúÀÇ Àú·ÅÇÑ Á¦Ç°À» »ý»êÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. »ý¸í°øÇÐ À¯·¡ Á¦Ç°, ü¿ÜÁø´ÜÁ¦, Ç×°¨¿°Á¦ µî ¸¹Àº »õ·Î¿î ºñ°æ±¸¿ë Á¦Ç°µéÀÌ µ¿°á°ÇÁ¶ Á¦Ç°À¸·Î »ý»êµÇ°í ÀÖ½À´Ï´Ù. ¼¼ÆÈ·Î½ºÆ÷¸°, ¹ÝÇÕ¼º Æä´Ï½Ç¸°, ¿¡¸®½º·Î¸¶À̽Š¿°, Ŭ·Î¶÷Æä´ÏÄÝ, µ¶½Ã»çÀÌŬ¸° µî ¸¹Àº Ç×»ýÁ¦°¡ µ¿°á°ÇÁ¶¹ýÀ¸·Î »ý»êµË´Ï´Ù. Ç×»ýÁ¦ Á¦Á¦¸¦ ¹èÄ¡ÇÒ ¶§ ³·Àº ¹ÙÀÌ¿À¹öµçÀ» ±â´ëÇÒ ¼ö Àִµ¥, ÀÌ´Â µ¿°á °ÇÁ¶¸¦ ÅëÇØ ´Þ¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ¸ÞÆ¿ ÇÁ·¹µå´Ï¼Ö·Ð ¼÷½Å»ê ³ªÆ®·ý, ÇÏÀ̵å·ÎÄÚ¸£Æ¼¼Õ ¼÷½Å»ê ³ªÆ®·ý ¹× ¸¹Àº »ý¸í°øÇÐ À¯·¡ Á¦Ç°°ú °°Àº ´Ù¸¥ ¿©·¯ Á¦Çüµµ µ¿°á°ÇÁ¶µË´Ï´Ù.

¶ÇÇÑ ÃÖ±Ù ¸î ³âµ¿¾È °³¹ß ¹× »ý»êµÇ´Â ¹ÙÀÌ¿À ÀǾàǰÀÇ ¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áö³­ ¸î ³âµ¿¾È ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ¸Å³â 10°¡Áö ÀÌ»óÀÇ »õ·Î¿î ¹ÙÀÌ¿À ÀǾàǰÀ» ½ÂÀÎÇßÀ¸¸ç, 2022³â 2¿ù FDA°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹ÙÀÌ¿À ÀǾàǰÀº FDA°¡ ½ÂÀÎÇÑ Àüü ÀǾàǰÀÇ 25% ÀÌ»óÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. À̵é Á¦Ç°ÀÇ ´ëºÎºÐÀº ¼ö¼º Á¦Á¦·Î¼­ ¾ÈÁ¤ÀûÀÌÁö ¾Ê±â ¶§¹®¿¡ Àå±â º¸°üÀÌ ¾î·Æ½À´Ï´Ù. ´õ ±ä »ó¾÷ÀûÀ¸·Î ½ÇÇà °¡´ÉÇÑ ÀúÀå ±â°£À» ´Þ¼ºÇϱâ À§ÇØ µ¿°á °ÇÁ¶´Â °ÇÁ¶ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¦ Á¦Á¶¿¡ ¼±È£µË´Ï´Ù. 2019³â 10¿ù ·çºê¸®Á¹ »ý¸í°úÇÐÀÌ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ½ÃÀå ³» »ý¹° ÀǾàǰ »ý»êÀÇ 60% ÀÌ»óÀÌ µ¿°á°ÇÁ¶ ¾øÀÌ´Â ºÒ°¡´ÉÇϸç, ¹ÙÀÌ¿À½Ã¹Ð·¯ ¹× ½Å±Ô »ý¹° ÀǾàǰÀÇ °³¹ßÀÌ Áõ°¡ÇÔ¿¡ µû¶ó µ¿°á°ÇÁ¶ ±â¼ú¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¹æ¹ýÀº »ý¹°ÇÐÀû Á¦Á¦ÀÇ Á¤È®ÇÑ Åõ¿©·®(¿¹: ¸Å¿ì ÀûÀº ¾çÀÇ °í³óµµ Åõ¿©·®)À» Á¦°øÇÏ´Â µ¿½Ã¿¡ ¾ÈÁ¤¼º¿¡ ¹®Á¦°¡ ÀÖÀ» ¶§ À¯¿ëÇÏ´Ù´Â °ÍÀÌ ÀÔÁõµÆ½À´Ï´Ù. ¶ÇÇÑ ¿­, »ê¼Ò, ½Àµµ¿¡ ¹Î°¨ÇÑ »ý¹°ÇÐÀû Á¦Á¦¿¡µµ ÀûÇÕÇÕ´Ï´Ù.

µ¿°á°ÇÁ¶´Â ÀǾàǰÀÇ ¾ÈÁ¤È­ ¹× º¸Á¸±â°£À» ¿¬ÀåÇÒ ¼ö Àֱ⠶§¹®¿¡ ¹Ý¼¼±â ÀÌ»ó Á¦¾à¾÷°è¿¡¼­ »ç¿ëµÇ¾î ¿ÔÁö¸¸, »ý¹°ÇÐÀû Á¦Á¦ °³¹ßÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¾÷üÀÇ °ü½ÉÀº °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀúºÐÀÚ ¹× °íºÐÀÚ ÀǾàǰÀÇ º¸Á¸ ±â°£À» ¿¬ÀåÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀǾàǰ °³¹ß ±â¾÷µéÀº µ¿°á °ÇÁ¶¸¦ äÅÃÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. º¹ÀâÇÑ ¿ø·áÀǾàǰ°ú »ý¹°ÇÐÀû Á¦Á¦ÀÇ Á¦Á¦ ¾ÈÁ¤¼º ¹®Á¦°¡ ³Î¸® ÆÛÁ® Àֱ⠶§¹®¿¡ ´ëºÎºÐÀÇ Á¦¾à»ç¿Í »ý¸í°øÇÐ Á¦Á¶¾÷ü´Â µ¿°á°ÇÁ¶ °øÁ¤À» äÅÃÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÀϺΠ°ø±Þ¾÷üµéÀÌ ¶óÀÌ¿À·¹µð Á¦Ç°À̳ª µ¿°á°ÇÁ¶µÈ Á¦Ç°À» ½ÃÀå¿¡ Ãâ½ÃÇÔ¿¡ µû¶ó µ¿°á°ÇÁ¶´Â »ý¸í°øÇÐ »ê¾÷¿¡¼­µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó µ¿°á°ÇÁ¶ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¹ÙÀÌ¿À ÀǾàǰ¿ë µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ¼¼ºÐÈ­´Â ´ÙÀ½°ú °°½À´Ï´Ù.

¼­ºñ½º À¯Çü¿¡ µû¶ó ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀº »ó¾÷Àû Á¦Á¶, µ¿°á°ÇÁ¶ »çÀÌŬ °³¹ß, ÀÓ»ó Á¦Á¶, µ¿°á°ÇÁ¶ ºÐ¼® ¼­ºñ½º·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â »ó¾÷Àû Á¦Á¶ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µ¿°á °ÇÁ¶ »çÀÌŬ °³¹ß ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ¿¡ µû¶ó ¼¼°è ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀåÀº Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ¿¬±¸±â°ü, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¿¬±¸ ±â°ü ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO), ¹Ì±¹ ½ÄǰÀǾ౹(FDA), À¯·´Á¦¾à»ê¾÷Çùȸ(European Federation of Pharmaceutical Industry Associations), ¹Ì±¹Á¦¾à¿¬±¸Á¦Á¶ÀÚÇùȸ(Pharmaceutical Research, and Manufacturers of America) µîÀº ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå º¸°í¼­¸¦ ÀÛ¼ºÇϱâ À§ÇØ Âü°íÇÑ ÁÖ¿ä 1Â÷ ¹× 2Â÷ Á¶»ç ÀÚ·áÀÔ´Ï´Ù. and Manufacturers of America) µîÀº ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ ÁÖ¿ä 1Â÷ Á¶»ç ¹× 2Â÷ Á¶»ç Á¤º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : ÁÖ¿ä ¿äÁ¡

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : ½ÃÀå ±¸µµ

  • PEST ºÐ¼®
    • ºÏ¹ÌÀÇ PEST ºÐ¼®
    • À¯·´ÀÇ PEST ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ PEST ºÐ¼®
    • Áß³²¹ÌÀÇ PEST ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ PEST ºÐ¼®
  • Àü¹®°¡ÀÇ °ßÇØ

Á¦5Àå ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀΰú ÀúÇØ¿äÀÎÀÇ ¿µÇ⠺м®

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ºÐ¼®

  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ¸ÅÃâ ¿¹Ãø°ú ºÐ¼®
  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : Áö¿ªº° ¿¹Ãø°ú ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ºÐ¼®°ú 2028³â±îÁö ¿¹Ãø : ¼­ºñ½º À¯Çüº°

  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : ¼­ºñ½º À¯Çüº°, 2022³â & 2028³â(%)
  • »ó¾÷¿ë Á¦Á¶
  • ÀÓ»ó Á¦Á¶
  • µ¿°á°ÇÁ¶ »çÀÌŬ °³¹ß
  • µ¿°á°ÇÁ¶ ºÐ¼® ¼­ºñ½º

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ºÐ¼®°ú 2028³â±îÁö ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2022³â & 2028³â(%)
  • Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦9Àå ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå - ¸ÅÃâ°ú ¿¹Ãø(-2028³â) : Áö¿ª ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦10Àå COVID-19 ÆÒµ¥¹ÍÀÌ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì

Á¦11Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå - ¾÷°è »óȲ

  • ¹ÙÀÌ¿ÀÀǾàǰ µ¿°á°ÇÁ¶ ¼­ºñ½º ½ÃÀå ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • ATTWILL Medical Solutions
  • Axcellerate Pharma LLC
  • Labyrinth BioPharma LLC
  • Berkshire Sterile Manufacturing
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC.
  • Biofortuna
  • Lyophilization Technology, Inc.
  • SYNERLAB GROUP

Á¦13Àå ºÎ·Ï

LSH 23.07.19

The lyophilization services for biopharmaceuticals market is expected to grow from US$ 2.05 billion in 2022 to US$ 3.58 billion by 2028; it is estimated to register a CAGR of 9.9% from 2023 to 2028.

The lyophilization services for biopharmaceuticals market growth is attributed to the rising demand for lyophilized products and rapidly growing contract manufacturing and lyophilization services across the world. However, the demerits associated with lyophilization process hinder the lyophilization services for biopharmaceuticals market growth.

Rising Demand for Lyophilized Products Drives Lyophilization Services for Biopharmaceuticals Market Growth

Lyophilization is a freeze drying method that removes water from the material to extend its stability and shelf life. The products processed under lyophilization are frozen under high vacuum that is majorly used for application in pharmaceutical industries to manufacture high quality and affordable products. Many new parenteral products, including biotechnology-derived products, in-vitro diagnostics, and anti-infectives, are manufactured as lyophilized products. Many antibiotics such as some cephalosporins, semi-synthetic penicillin, erythromycin salts, chloramphenicol, and doxycycline are made by the lyophilization process. Low bioburden is expected when batching antibiotics formulations, which can be attained using lyophilization. Similarly, a few other dosage forms such as methylprednisolone sodium succinate, hydrocortisone sodium succinate, and many biotechnology-derived products are lyophilized.

Additionally, the number of biopharmaceuticals being developed and manufactured has increased considerably in recent years. Over ten novel biologics have been approved annually by the US Food and Drug Administration (FDA) in the last few years. According to the data published by FDA in February 2022, biologics continue to account for slightly more than 25% of all drugs accepted by the FDA. Most of these products are not stable as aqueous formulations, making it challenging to preserve them for longer durations. To achieve longer and commercially viable shelf lives, lyophilization is preferred for making dry biopharmaceutical formulations. According to the data published by Lubrizol Life Science, in October 2019, over 60% of biologics production in the market would not be possible without lyophilization, and market demand for lyophilization technology will increase due to the growing biosimilars and novel biologics development. The method proves to be beneficial when there is a stability issue while providing exact biologics dosage (for instance, very small and highly concentrated doses). Furthermore, it is suitable for biologics that are sensitive to heat, oxygen, and humidity.

Although lyophilization has been used for more than half a century in the drug product manufacturing industry owing to its ability to stabilize and extend the shelf life of pharmaceutical products, thus interest of biopharmaceutical manufacturers continues to grow, mainly due to the increasing number of biological drug development. Drug developers are focusing on adopting lyophilization as it can extend the shelf life of small and large-molecule drugs. The prevalence of formulation stability challenges for complex APIs and biologics has resulted in the adoption of lyophilization among most pharmaceutical and biotech manufacturers.

Further, lyophilization become important in the biotech industry, as several suppliers are introducing lyo-ready or pre-lyophilized products to the marketplace. As a result, the demand for lyophilization services is growing rapidly, which is driving the growth of the lyophilization services for biopharmaceuticals market.

The Report Segments of Lyophilization Services for Biopharmaceuticals Market are as Follows.

Based on service type, the global lyophilization services for biopharmaceuticals market is segmented into commercial manufacturing, lyophilization cycle development, clinical manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2022. The lyophilization cycle development segment is expected to register the highest CAGR during the forecast period.

Based on end user, the global lyophilization services for biopharmaceuticals market is segmented into pharmaceutical and biotechnology companies, research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest market share in 2022. The research institutes segment is expected to register the highest CAGR during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), European Federation of Pharmaceutical Industry Associations, and Pharmaceutical Research, and Manufacturers of America are among the major primary and secondary sources referred to while preparing the report on the lyophilization services for biopharmaceuticals market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the lyophilization services for biopharmaceuticals market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies. 
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Lyophilization Services for Biopharmaceuticals Market - by Service Type
    • 1.3.2 Global Lyophilization Services for Biopharmaceuticals Market - by End User
    • 1.3.3 Global Lyophilization Services for Biopharmaceuticals Market - by Geography

2. Lyophilization Services for Biopharmaceuticals Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Lyophilization Services for Biopharmaceuticals Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics

  • 5.1 Market Driver
    • 5.1.1 Rising Demand for Lyophilized Products
    • 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
  • 5.2 Market Restraints
    • 5.2.1 Demerits Associated with Lyophilization Process
  • 5.3 Market Opportunities
    • 5.3.1 Launch of Advanced Lyophilization Technology
  • 5.4 Future Trends
    • 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
  • 5.5 Impact Analysis of Drivers and Restraints

6. Lyophilization Services for Biopharmaceuticals Market - Global Analysis

  • 6.1 Global Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis
  • 6.2 Global Lyophilization Services for Biopharmaceuticals Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type

  • 7.1 Overview
  • 7.2 Global Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
  • 7.3 Commercial Manufacturing
    • 7.3.1 Overview
    • 7.3.2 Commercial Manufacturing: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Clinical Manufacturing
    • 7.4.1 Overview
    • 7.4.2 Clinical Manufacturing: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Lyophilization Cycle Development
    • 7.5.1 Overview
    • 7.5.2 Lyophilization Cycle Development: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Freeze Drying Analytical Services
    • 7.6.1 Overview
    • 7.6.2 Freeze Drying Analytical Services: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User

  • 8.1 Overview
  • 8.2 Global Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
  • 8.3 Pharmaceutical and Biotechnology Companies
    • 8.3.1 Overview
    • 8.3.2 Pharmaceutical and Biotechnology Companies: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Research Institutes
    • 8.4.1 Overview
    • 8.4.2 Research Institutes: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

9. Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 9.1 North America: Lyophilization Services for Biopharmaceuticals Market
    • 9.1.1 Overview
    • 9.1.2 North America: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 North America: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    • 9.1.4 North America: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
    • 9.1.5 North America: Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.1.5.1 US: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.1 Overview
        • 9.1.5.1.2 US: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.3 US: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.5.1.4 US Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.5.2 Canada: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.1 Overview
        • 9.1.5.2.2 Canada: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.3 Canada: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.5.2.4 Canada: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.5.3 Mexico: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.1 Overview
        • 9.1.5.3.2 Mexico: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.3 Mexico: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.5.3.4 Mexico: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  • 9.2 Europe: Lyophilization Services for Biopharmaceuticals Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Europe: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    • 9.2.4 Europe: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
    • 9.2.5 Europe: Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.2.5.1 Germany: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 Overview
        • 9.2.5.1.2 Germany: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.3 Germany: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.1.4 Germany: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.2.5.2 France: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 Overview
        • 9.2.5.2.2 France: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.3 France: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.2.4 France: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.2.5.3 UK: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 Overview
        • 9.2.5.3.2 UK: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.3 UK: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.3.4 UK: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.2.5.4 Italy: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Overview
        • 9.2.5.4.2 Italy: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.3 Italy: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.4.4 Italy: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.2.5.5 Spain: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.1 Overview
        • 9.2.5.5.2 Spain: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.3 Spain: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.5.4 Spain: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.2.5.6 Rest of Europe: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.1 Overview
        • 9.2.5.6.2 Rest of Europe: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.3 Rest of Europe: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.2.5.6.4 Rest of Europe: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  • 9.3 Asia Pacific: Lyophilization Services for Biopharmaceuticals Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.3.3 Asia Pacific: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    • 9.3.4 Asia Pacific: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
    • 9.3.5 Asia Pacific: Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.3.5.1 China: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.1 Overview
        • 9.3.5.1.2 China: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.1.3 China: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.1.4 China Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.3.5.2 Japan: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.1 Overview
        • 9.3.5.2.2 Japan: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.2.3 Japan: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.2.4 Japan: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.3.5.3 India: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.1 Overview
        • 9.3.5.3.2 India: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.3.3 India: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.3.4 India: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.3.5.4 South Korea: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.1 Overview
        • 9.3.5.4.2 South Korea: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.4.3 South Korea: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.4.4 South Korea: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.3.5.5 Australia: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.1 Overview
        • 9.3.5.5.2 Australia: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.5.3 Australia: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.5.4 Australia: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.3.5.6 Rest of Asia Pacific: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Overview
        • 9.3.5.6.2 Rest of Asia Pacific: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.3 Rest of Asia Pacific: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.3.5.6.4 Rest of Asia Pacific: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  • 9.4 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    • 9.4.4 Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
    • 9.4.5 Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.4.5.1 Saudi Arabia: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.1 Overview
        • 9.4.5.1.2 Saudi Arabia: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.1.3 Saudi Arabia: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.4.5.1.4 Saudi Arabia: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.4.5.2 South Africa: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.1 Overview
        • 9.4.5.2.2 South Africa: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.2.3 South Africa: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.4.5.2.4 South Africa: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.4.5.3 UAE: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.1 Overview
        • 9.4.5.3.2 UAE: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.3.3 UAE: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.4.5.3.4 UAE: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.4.5.4 Rest of Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.4.5.4.3 Rest of Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.4.5.4.4 Rest of Middle East & Africa: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
  • 9.5 South & Central America Lyophilization Services for Biopharmaceuticals Market
    • 9.5.1 Overview
    • 9.5.2 South & Central America: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.5.3 South & Central America: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
    • 9.5.4 South & Central America: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
    • 9.5.5 South & Central America: Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.5.5.1 Brazil: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.1.1 Overview
        • 9.5.5.1.2 Brazil: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.1.3 Brazil: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.5.5.1.4 Brazil: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.5.5.2 Argentina: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.2.1 Overview
        • 9.5.5.2.2 Argentina: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.2.3 Argentina: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.5.5.2.4 Argentina: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.5.5.3 Rest of South & Central America: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.3.1 Overview
        • 9.5.5.3.2 Rest of South & Central America: Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.3.3 Rest of South & Central America: Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.5.5.3.4 Rest of South & Central America: Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)

10. Impact of COVID-19 Pandemic on Lyophilization Services for Biopharmaceuticals Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South & Central America: Impact Assessment of COVID-19 Pandemic

11. Global Lyophilization Services for Biopharmaceuticals Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Lyophilization Services for Biopharmaceuticals Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 ATTWILL Medical Solutions
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Axcellerate Pharma LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Labyrinth BioPharma LLC
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Berkshire Sterile Manufacturing
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 PCI Pharma Services
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curia Global Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Emergent BioSolutions Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Jubilant HollisterStier LLC.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Biofortuna
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Lyophilization Technology, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 SYNERLAB GROUP
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦